TNNT1 nemaline myopathy: natural history and therapeutic frontier
Authors:
- 20 June 2018
- journal article
- research article
- Published by Oxford University Press (OUP) in Human Molecular Genetics
- Vol. 27 (18) , 3272-3282
Abstract
We describe the natural history of 'Amish' nemaline myopathy (ANM), an infantile-onset, lethal disease linked to a pathogenic c.505G>T nonsense mutation of TNNT1, which encodes the slow fiber isoform of troponin T (TNNT1; a.k.a. TnT). The TNNT1 c.505G>T allele has a carrier frequency of 6.5% within Old Order Amish settlements of North America. We collected natural history data for 106 ANM patients born between 1923 and 2017. Over the last two decades, mean age of molecular diagnosis was 16 ± 27 days. TNNT1 c.505G>T homozygotes were normal weight at birth but failed to thrive by age 9 months. Presenting neonatal signs were axial hypotonia, hip and shoulder stiffness, and tremors, followed by progressive muscle weakness, atrophy and contractures. Affected children developed thoracic rigidity, pectus carinatum and restrictive lung disease during infancy, and all succumbed to respiratory failure by 6 years of age (median survival 18 months, range 0.2-66 months). Muscle histology from two affected children showed marked fiber size variation owing to both Type 1 myofiber smallness (hypotrophy) and Type 2 fiber hypertrophy, with evidence of nemaline rods, myofibrillar disarray and vacuolar pathology in both fiber types. The truncated slow TNNT1 (TnT) fragment (p.Glu180Ter) was undetectable in ANM muscle, reflecting its rapid proteolysis and clearance from sarcoplasm. Similar functional and histological phenotypes were observed in other human cohorts and two transgenic murine models (Tnnt1-/- and Tnnt1 c.505G>T). These findings have implications for emerging molecular therapies, including the suitably of TNNT1 gene replacement for newborns with ANM or other TNNT1-associated myopathies.Keywords
Funding Information
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (AR048816)
This publication has 44 references indexed in Scilit:
- Long‐term effects of systemic gene therapy in a canine model of myotubular myopathyMuscle & Nerve, 2017
- Protein Structure-Function Relationship at Work: Learning from Myopathy Mutations of the Slow Skeletal Muscle Isoform of Troponin TFrontiers in Physiology, 2016
- Deficiency of slow skeletal muscle troponin T causes atrophy of type I slow fibres and decreases tolerance to fatigueThe Journal of Physiology, 2014
- Effect of Genome Size on AAV Vector PackagingMolecular Therapy, 2010
- Truncation by Glu180 Nonsense Mutation Results in Complete Loss of Slow Skeletal Muscle Troponin T in a Lethal Nemaline MyopathyJournal of Biological Chemistry, 2003
- The Highly Conserved COOH Terminus of Troponin I Forms a Ca2+-Modulated Allosteric Domain in the Troponin ComplexBiochemistry, 2001
- Conformational modulation of slow skeletal muscle troponin T by an NH2-terminal metal-binding extensionAmerican Journal of Physiology-Cell Physiology, 2000
- Nemaline myopathy of catsMuscle & Nerve, 1986
- Nemaline MyopathyNew England Journal of Medicine, 1966
- Hereditary Occurrence of Nemaline MyopathyArchives of Neurology, 1965